Skip to main content
opinion

The sweetened offer from Hudson’s Bay Co. executive chairman Richard Baker to the retailer’s minority shareholders looks set to end a stalemate that was sure to bring pain to all sides.

Catalyst Capital Group Inc.’s hardball tactics in the battle for Canada’s oldest corporation paid off. The Toronto-based private-equity fund led by financier Newton Glassman had a 17.5-per-cent stake in HBC and became the loudest critic of the buyout first announced in early June. The agreed-upon bid price – although far below what dissident investors have contended HBC is worth – prevents further erosion in the shares as the department-store sector struggles against online competition.

Late Friday, Catalyst pledged its support for an $11-a-share bid from Mr. Baker and his fellow controlling shareholders. That is 70 cents higher than the previous offer that minority shareholders spurned despite the HBC board’s recommendation. It is also the price Catalyst itself had previously proposed to offer for the owner of the Hudson’s Bay and Saks Fifth Avenue banners.

The offer, at more than $1-billion, is no windfall for shareholders including Catalyst, which will sell its shares for 8.8 per cent more than it bought most of its interest, said Julian Klymochko, veteran arbitrageur and chief executive of Accelerate Financial Technology Inc. But it is a better alternative than the deal falling apart.

“The worst-case scenario is to end up in that purgatory where the stock tanks 50 per cent and there’s really no hope for public shareholders. So it is a small win here,” Mr. Klymochko said.

Before taxes, Catalyst will make a profit of about $16.5-million on the 18.5 million shares it bought in a mini-tender last summer at $10.11 each. It has not disclosed the price it paid for the other 13.7-million shares it bought previously, but proceeds will likely be much higher.

None of the players involved in the deal would comment on Sunday about what led to the break in the acrimony.

Catalyst’s stake, along with that of other minority shareholders, was enough to block the bid by Mr. Baker and his allies, which include Rhone Capital LLC, Hanover Investments (Luxembourg) SA and Abrams Capital Management LP. Although the Baker group collectively controlled 57 per cent of HBC shares, a majority of minority shareholders had to vote in favour for a buyout to be successful.

Catalyst opposed the Baker group on several fronts, including launching a complaint with the Ontario Securities Commission that resulted in HBC having to postpone the shareholder vote. It appeared the bid was set to fail anyway, as minority holders stuck to their view that the value of the offer did not reflect the worth of HBC’s real estate.

A major point of debate is the flagship Saks store in Manhattan. In 2014, it was valued by a lender at $4.1-billion. This fall, real estate appraisers pegged it at $2.1-billion – with $1.64-billion in debt. HBC argued that the deteriorating retail landscape, especially on that New York strip, had hurt the value. Investors did not buy the explanation, which was part of the calculation that HBC’s real estate was worth $8.75 of the last offer.

Mr. Baker wants to restructure HBC away from the public spotlight, and the prospect of the takeover battle dragging on would only hurt those efforts. The stock has weakened despite several asset sales and store closings, as the business environment has worsened. The shares traded at nearly $29 in 2015, but had fallen to $6.22 just before Mr. Baker announced his privatization plan.

Not all minority shareholders are enamoured with the 6.8-per-cent increase in the bid. Sandpiper Group, a real estate private equity company, said HBC is worth significantly more but added, “it is a good outcome to arrive at given the controlling shareholder group involved.” Alyssa Barry, Sandpiper’s vice-president of capital markets, declined to say if the firm now will vote in favour of the bid.

Another dissident, Ortelius Advisors LP, will proceed with a lawsuit against HBC and Mr. Baker, according to a spokesman. The New York activist hedge fund is seeking an injunction against the deal, arguing that HBC is understating the true value of the property and presenting “misleading negative views” of the company’s prospects.

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe